Scientists in China say they have developed an optical fibre technology that could pave the way for real-time endoscopies of nerve cells in the brain, as well as faster next-gen telecommunications.

Mirdametinib earned FDA approval for the treatment of inoperable plexiform neurofibromas associated with neurofibromatosis type 1, marking the first on-label option for adults. The decision highlights ...

Surgical removal of these tumors can be challenging due to the infiltrative tumor growth pattern along nerves and can lead to permanent nerve damage and disfigurement. 6 Up to approximately 85% of ...

Refinements in both noninvasive and invasive imaging techniques have led to significant improvements in both the diagnosis and treatment of peripheral arterial disease. Multiple complementary ...

Objective: Peripheral nerve sheath tumors (PNSTs) commonly arise from peripheral nerve roots and grow locally ... was either proven histologically or defined radiologically as residual tumor ...

Introduction Nerve sheath tumours arise from both the central and peripheral nervous systems. In particular ... 6 19 23–25 On presentation, the diagnosis is usually established with the help of MRI.

Selumetinib sulfate is under clinical development by AstraZeneca and currently in Phase II for Peripheral Nerve Sheath Tumor (Neurofibrosarcoma). According to GlobalData, Phase II drugs for Peripheral ...

Background: Sporadic Spinal Psammomatous Malignant Melanotic Nerve Sheath Tumor (SSP-MMNST) is a rare subgroup of peripheral nerve sheath tumors arising along the spine ... Spinal cord Magnetic ...

Peripheral neuropathies (often painful damage or disruption of the peripheral nerve function) affect millions of Americans, but sadly, most have no effective treatments. The Johns Hopkins Merkin ...